FDA.reportPublic FDA data

treprostinil 106 MCG Inhalation Powder

RxCUI
2714674
RxNorm name
treprostinil 106 MCG Inhalation Powder
Display name
treprostinil 106 MCG Inhalation Powder
Full name
treprostinil 106 MCG Inhalation Powder
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:26

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YutrepiaTREPROSTINILLiquidia Technologies, Inc.e8f6d534-115c-440e-bdbb-b443a29bb4682025-09-08Warnings, Adverse reactionsExact identifier
rxcui: 2714674

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
e8f6d534-115c-440e-bdbb-b443a29bb468treprostinil 106 MCG Inhalation Powder [PSN] · treprostinil 0.106 MG Inhalation Powder [SCD] · treprostinil 106 MCG (as treprostinil sodium) Inhalation Powder [SY] · treprostinil 106 MCG Inhalation Powder [SY]43These highlights do not include all the information needed to use YUTREPIA™ safely and effectively. See full prescribing information for YUTREPIA™ . YUTREPIA™ (treprostinil) inhalation powder, for oral inhalation Initial U.S. Approval: 200220250908